Company Filing History:
Years Active: 2022
Title: Innovations of Xiaoyi Ji in Biotechnology
Introduction
Xiaoyi Ji is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of selective inhibitors for therapeutic applications. His work focuses on addressing diseases modulated by cyclin-dependent kinases.
Latest Patents
Xiaoyi Ji holds a patent for a selective CDK4/6 inhibitor and its preparation. The patent discloses a compound represented by a specific formula, which can be a pharmaceutically acceptable salt, solvate, or stereoisomer. This compound serves as a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6) and may be utilized for treating or preventing diseases influenced by CDK4/6. He has 1 patent to his name.
Career Highlights
Xiaoyi Ji is associated with Wuxi Shuangliang Biotechnology Co., Ltd., where he applies his expertise in drug development. His innovative approach has positioned him as a key figure in the biotechnology sector.
Collaborations
Some of his notable coworkers include Jiaquan Wu and Feng Fan, who contribute to the collaborative efforts in their research and development projects.
Conclusion
Xiaoyi Ji's work in developing selective CDK4/6 inhibitors showcases his commitment to advancing biotechnology. His contributions are vital for the ongoing research in therapeutic solutions for diseases influenced by cyclin-dependent kinases.